Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Related Posts OPINION — Goldenomics 104: Trump’s Tariffs and Gold August 23, 2025 Grande Portage Applies for Road Easement from State of Alaska August 23, 2025 Crypto Market Update: World Liberty Gets Coinbase Approval with Stablecoin Listing August 23, 2025